<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN" "http://jats.nlm.nih.gov/publishing/1.1d3/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.1d3" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id>
<journal-title-group>
<journal-title>PLOS ONE</journal-title>
</journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1371/journal.pone.0180271</article-id>
<article-id pub-id-type="publisher-id">PONE-D-16-36518</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Oncology</subject><subj-group><subject>Cancers and neoplasms</subject><subj-group><subject>Gastrointestinal tumors</subject><subj-group><subject>Esophageal cancer</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Oncology</subject><subj-group><subject>Cancers and neoplasms</subject><subj-group><subject>Carcinomas</subject><subj-group><subject>Squamous cell carcinomas</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Oncology</subject><subj-group><subject>Metastasis</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Oncology</subject><subj-group><subject>Basic cancer research</subject><subj-group><subject>Metastasis</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Lymphatic system</subject><subj-group><subject>Lymph nodes</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Lymphatic system</subject><subj-group><subject>Lymph nodes</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Digestive system</subject><subj-group><subject>Gastrointestinal tract</subject><subj-group><subject>Esophagus</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Digestive system</subject><subj-group><subject>Gastrointestinal tract</subject><subj-group><subject>Esophagus</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Mathematical and statistical techniques</subject><subj-group><subject>Statistical methods</subject><subj-group><subject>Meta-analysis</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical sciences</subject><subj-group><subject>Mathematics</subject><subj-group><subject>Statistics (mathematics)</subject><subj-group><subject>Statistical methods</subject><subj-group><subject>Meta-analysis</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Database and informatics methods</subject><subj-group><subject>Database searching</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Diagnostic medicine</subject><subj-group><subject>Prognosis</subject></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>The prognostic and clinicopathologic characteristics of CD147 and esophagus cancer: A meta-analysis</article-title>
<alt-title alt-title-type="running-head">CD147 and esophagus cancer: A meta-analysis</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes" equal-contrib="yes" xlink:type="simple">
<name name-style="western">
<surname>Li</surname>
<given-names>Hui</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Project administration</role>
<role content-type="http://credit.casrai.org/">Software</role>
<role content-type="http://credit.casrai.org/">Supervision</role>
<role content-type="http://credit.casrai.org/">Writing – original draft</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="corresp" rid="cor001">*</xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes" xlink:type="simple">
<name name-style="western">
<surname>Jiang</surname>
<given-names>Chunxiang</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Software</role>
<role content-type="http://credit.casrai.org/">Writing – original draft</role>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes" xlink:type="simple">
<name name-style="western">
<surname>Wu</surname>
<given-names>Dongwen</given-names>
</name>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Software</role>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Shi</surname>
<given-names>Shupeng</given-names>
</name>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Liao</surname>
<given-names>Mengting</given-names>
</name>
<role content-type="http://credit.casrai.org/">Data curation</role>
<xref ref-type="aff" rid="aff003"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Wang</surname>
<given-names>Jing</given-names>
</name>
<role content-type="http://credit.casrai.org/">Data curation</role>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Li</surname>
<given-names>Yanwen</given-names>
</name>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Xu</surname>
<given-names>Zihao</given-names>
</name>
<role content-type="http://credit.casrai.org/">Data curation</role>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
</contrib-group>
<aff id="aff001"><label>1</label> <addr-line>Reproductive Department, Xiangya Hospital, Central South University, Changsha, China</addr-line></aff>
<aff id="aff002"><label>2</label> <addr-line>Xiangya School of Medicine, Central South University, Changsha, China</addr-line></aff>
<aff id="aff003"><label>3</label> <addr-line>Oncology department of Xiangya Hospital, Central South University, Changsha, China</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple">
<name name-style="western">
<surname>Suzuki</surname>
<given-names>Hiromu</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/>
</contrib>
</contrib-group>
<aff id="edit1"><addr-line>Sapporo Ika Daigaku, JAPAN</addr-line></aff>
<author-notes>
<fn fn-type="conflict" id="coi001">
<p>The authors have declared that no competing interests exist.</p>
</fn>
<corresp id="cor001">* E-mail: <email xlink:type="simple">HUILI257@hotmail.com</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>11</day>
<month>7</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<volume>12</volume>
<issue>7</issue>
<elocation-id>e0180271</elocation-id>
<history>
<date date-type="received">
<day>12</day>
<month>9</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>13</day>
<month>6</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-year>2017</copyright-year>
<copyright-holder>Li et al</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="info:doi/10.1371/journal.pone.0180271"/>
<abstract>
<sec id="sec001">
<title>Objective</title>
<p>The prognostic significance of CD147 expression in esophageal cancer patients remains controversial. Using a meta-analysis, we investigated the prognostic and clinicopathologic characteristics of CD147 in esophageal cancer.</p>
</sec>
<sec id="sec002">
<title>Methods</title>
<p>A comprehensive literature search of the PubMed (1966–2016), EMBASE (1980–2016), Cochrane Library (1996–2016), Web of Science (1945–2016), China National Knowledge Infrastructure (1982–2016), and Wanfang databases (1988–2016) was performed to identify studies of all esophageal cancer subtypes. Correlations between CD147 expression and survival outcomes and clinicopathological features were analyzed using meta-analysis methods.</p>
</sec>
<sec id="sec003">
<title>Results</title>
<p>Seventeen studies were included. High CD147 expression reduced the 3-year survival rate (OR = 3.26, 95% CI = (1.53, 6.93), p = 0.02) and 5-year survival rate(OR = 4.35, 95% CI = (2.13, 8.90), p &lt; 0.0001). High CD147 expression reduced overall survival in esophageal cancer (HR = 1.60, 95% CI = (1.19, 2.15), p = 0.02). Additionally, higher CD147 expression was detected in esophageal cancer tissues than noncancerous tissues (OR = 9.45, 95% CI = (5.39, 16.59), p &lt; 0.00001), normal tissues (OR = 12.73, 95% CI = (3.49, 46.46), p = 0.0001), para-carcinoma tissues (OR = 12.80, 95% CI = (6.57, 24.92), p &lt; 0.00001), and hyperplastic tissues (OR = 3.27, 95% CI = (1.47, 7.29), p = 0.004). CD147 expression was associated with TNM stage (OR = 3.66, 95% CI = (2.20, 6.09), p &lt; 0.00001), tumor depth (OR = 7.97, 95% CI = (4.13, 15.38), p &lt; 0.00001), and lymph node status (OR = 5.14, 95% CI = (2.03,13.01), p = 0.0005), but not with tumor differentiation, age, or sex.</p>
</sec>
<sec id="sec004">
<title>Conclusion</title>
<p>Our meta-analysis suggests that CD147 is an efficient prognostic factor in esophageal cancer. High CD147 expression in patients with esophageal cancer was associated with worse survival outcomes and common clinicopathological indicators of poor prognosis.</p>
</sec>
</abstract>
<funding-group>
<funding-statement>The author(s) received no specific funding for this work.</funding-statement>
</funding-group>
<counts>
<fig-count count="4"/>
<table-count count="3"/>
<page-count count="15"/>
</counts>
<custom-meta-group>
<custom-meta id="data-availability">
<meta-name>Data Availability</meta-name>
<meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="sec005" sec-type="intro">
<title>Introduction</title>
<p>Esophagus cancer (EC) is a malignant disease with the eighth incidence rate and the sixth mortality rate wordwide[<xref ref-type="bibr" rid="pone.0180271.ref001">1</xref>, <xref ref-type="bibr" rid="pone.0180271.ref002">2</xref>]. The prognosis of EC is unfavorable, largely due to its unapparent symptom at the early stage and tumor infiltration and metastasis which makes it hard to completely remove the tumor by surgery[<xref ref-type="bibr" rid="pone.0180271.ref003">3</xref>]. Therefore, it is with great significance to study the molecular mechanism in the development, invasion and metastasis of EC. Up to now, it is proved that the expression of some molecules, such as NF-kappaB, MIF, CXCR4 and EGFR, are related to the treatment or the prognosis of EC[<xref ref-type="bibr" rid="pone.0180271.ref004">4</xref>–<xref ref-type="bibr" rid="pone.0180271.ref006">6</xref>].</p>
<p>CD147, also named extracellular matrix (ECM) metalloproteinase inducer, is a molecule highly expressed on the surface of cancer cells and promotes the secretion of matrix metalloproteinases (MMPs) from fibroblasts, degrading the matrix of cancer cell and thus facilitating the invasion and metastasis of cancer[<xref ref-type="bibr" rid="pone.0180271.ref007">7</xref>, <xref ref-type="bibr" rid="pone.0180271.ref008">8</xref>]. Numerous papers showed that CD147 plays an important role in different sorts of cancer, including bladder cancer, prostate cancer, ovarian cancer, glioma, and esophageal cancer is also one of them[<xref ref-type="bibr" rid="pone.0180271.ref009">9</xref>–<xref ref-type="bibr" rid="pone.0180271.ref014">14</xref>].</p>
<p>Although evidence exists that CD147 is an important factor implicated in clinicopathological features and the prognosis of EC. Some conflicting results have been reported. Wan and Wu[<xref ref-type="bibr" rid="pone.0180271.ref015">15</xref>] reported the CD147 expression wasn’t associated with overall survival (OS), which contradictory with Zhu et al[<xref ref-type="bibr" rid="pone.0180271.ref016">16</xref>]. Some studies found that CD147 high Expression might be related to advanced clinical stage and lymph node metastasis[<xref ref-type="bibr" rid="pone.0180271.ref015">15</xref>, <xref ref-type="bibr" rid="pone.0180271.ref017">17</xref>]. But other studies reported that there was no significant difference between CD147 and clinical stage and lymph node metastasis[<xref ref-type="bibr" rid="pone.0180271.ref017">17</xref>, <xref ref-type="bibr" rid="pone.0180271.ref018">18</xref>]. Moreover, there are also arguments about relationship of the CD147 high expression with invasive depth, histological differentiation[<xref ref-type="bibr" rid="pone.0180271.ref016">16</xref>, <xref ref-type="bibr" rid="pone.0180271.ref018">18</xref>–<xref ref-type="bibr" rid="pone.0180271.ref020">20</xref>].</p>
<p>This controversial issue could be results of differences in sample sizes and other factors, such as the criteria of the CD147 high expression, and unfortunately evidence-based confirmation by large-scale clinical trials is still lacking. Therefore, we conducted this meta-analysis to quantitatively inspect the relationship between CD147 and clinicopathological features and survival of EC patients.</p>
</sec>
<sec id="sec006" sec-type="materials|methods">
<title>Methods and materials</title>
<sec id="sec007">
<title>Search strategy</title>
<p>We searched PubMed (1966–2016), EMBASE (1980–2016), the Cochrane Library (1996–2016), Web of Science (1945–2016), China National Knowledge Infrastructure (1982–2016), and the WanFang databases (1988–2016). The studies were restricted to humans, but not restricted by date, language, or publication status. The following combined search term was used:(Esophageal <ext-link ext-link-type="uri" xlink:href="http://cn.bing.com/dict/clientsearch?mkt=zh-CN&amp;setLang=zh&amp;form=BDVEHC&amp;ClientVer=BDDTV3.5.0.4311&amp;q=%E9%A3%9F%E7%AE%A1%E7%99%8C" xlink:type="simple">Cancer,</ext-link> <ext-link ext-link-type="uri" xlink:href="http://cn.bing.com/dict/clientsearch?mkt=zh-CN&amp;setLang=zh&amp;form=BDVEHC&amp;ClientVer=BDDTV3.5.0.4311&amp;q=%E9%A3%9F%E7%AE%A1%E7%99%8C" xlink:type="simple">esophageal carcinoma,</ext-link> <ext-link ext-link-type="uri" xlink:href="http://cn.bing.com/dict/clientsearch?mkt=zh-CN&amp;setLang=zh&amp;form=BDVEHC&amp;ClientVer=BDDTV3.5.0.4311&amp;q=%E9%A3%9F%E7%AE%A1%E8%82%BF%E7%98%A4" xlink:type="simple">esophageal neoplasms</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://cn.bing.com/dict/clientsearch?mkt=zh-CN&amp;setLang=zh&amp;form=BDVEHC&amp;ClientVer=BDDTV3.5.0.4311&amp;q=%E9%A3%9F%E7%AE%A1%E7%99%8C" xlink:type="simple">carcinoma of esophagus,</ext-link> esophageal tumor, <ext-link ext-link-type="uri" xlink:href="http://cn.bing.com/dict/clientsearch?mkt=zh-CN&amp;setLang=zh&amp;form=BDVEHC&amp;ClientVer=BDDTV3.5.0.4311&amp;q=%E9%A3%9F%E7%AE%A1%E6%81%B6%E6%80%A7%E8%82%BF%E7%98%A4" xlink:type="simple">Malignant Neoplasm of Oesophagus</ext-link>) AND (CD147, (extracellular AND matrix AND metalloproteinase AND inducer), extracellular MMP inducer, EMMPRIN, BSG) to identify relevant papers addressing all subtypes of esophageal cancer. We combined the term appropriately with MeSH Terms and used an appropriate adjustment for different databases. Details of the search strategies can be found in <xref ref-type="supplementary-material" rid="pone.0180271.s002">S1 File</xref>.</p>
</sec>
<sec id="sec008">
<title>Criteria for including studies</title>
<list list-type="order">
<list-item><p>Published or unpublished case control study or cohort study in English or Chinese with the full text available;</p></list-item>
<list-item><p>All cases had survival or clinical pathological characteristic data, without radiotherapy or chemotherapy or biological therapy before sampling;</p></list-item>
<list-item><p>Diagnosis of esophagus cancer was proven by pathological methods;</p></list-item>
<list-item><p>Studies of CD147 expression based on primary esophagus cancer tissues, rather than serum or any other kinds of indirect specimen were included;</p></list-item>
<list-item><p>The best quality study was retained for dealing duplicated studies.</p></list-item>
</list>
</sec>
<sec id="sec009">
<title>Criteria for excluding studies</title>
<list list-type="order">
<list-item><p>Cell or animal studies, case reports, letters, reviews;</p></list-item>
<list-item><p>The standard of pathological diagnosis was not clear.</p></list-item>
</list>
</sec>
<sec id="sec010">
<title>Assessment of included studies</title>
<p>The Newcastle-Ottawa quality assessment scale of case control studies (NOS)[<xref ref-type="bibr" rid="pone.0180271.ref021">21</xref>] was adopted to assess the quality of included studies, which has three categories (selection, comparability, and exposure) and eight items. The quality assessment values ranged from 0 to 9 stars. Studies scored more than 6 stars was included for our analysis.</p>
</sec>
<sec id="sec011">
<title>Statistical analysis</title>
<p>Records were independently scanned by two authors to exclude apparent irrelevant studies. Then, full text were independently reviewed by two authors, and controversial opinions about whether to include specific study were resolved by discussion. Data was extracted independently by two authors: Hui Li and Chunxiang Jiang. Excel was designed according to the Cochrane manual to extract data and the survival data from the Kaplan-Meier curve was obtained by using Engauge Digitizer software. The software Revman 5.3 and Stata 13.0 were applied to analyze the data. Results were showed with odds ratios (OR) or HR (hazard ratio) and 95% confidence intervals (95% CI). Fixed-effects model was adopted when there was no evidence of significant heterogeneity (p &gt; 0.1 and <italic>I</italic><sup>2</sup> &lt; 50%); otherwise, random-effects model was used. If possible, heterogeneity was explored and subgroup analyses were performed. All p values were 2-sided, and p &lt; 0.05 was considered significant.</p>
<p>Sensitivity analysis was also performed to evaluate the influence of individual study on the final effect if the parameter has more than two data sets, and different model was used for no more than two data sets.</p>
<p>Begg’s test was used to assess publication bias (p &lt;0.05 was considered statistically significant). If publication bias was confirmed, a trim-and-fill method developed by Duval and Tweedie[<xref ref-type="bibr" rid="pone.0180271.ref022">22</xref>] was implemented to adjust for this bias. Then, we replicated the funnel plot with their ‘‘missing” counterparts around the adjusted summary estimate.</p>
</sec>
</sec>
<sec id="sec012" sec-type="results">
<title>Results</title>
<sec id="sec013">
<title>Literature search</title>
<p>The literature searches revealed 64 studies, of which 21 studies were excluded owing to duplication. After reading the titles and abstracts, 20 studies were excluded. The full-length texts of 23 candidate studies were carefully reviewed (animal studies [n = 5]; review and meta-analysis [n = 2]; no control group [n = 2]). Finally, 17 trials were included in the quantitative analysis (<xref ref-type="fig" rid="pone.0180271.g001">Fig 1</xref>). Only Huang et al.[<xref ref-type="bibr" rid="pone.0180271.ref007">7</xref>] reported CD147 expression in type II/III adenocarcinoma of the esophagogastric junction (Type II/III AEGs). An association between CD147 and esophageal squamous cell carcinoma (ESCC) was reported in 16 studies.</p>
<fig id="pone.0180271.g001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0180271.g001</object-id>
<label>Fig 1</label>
<caption>
<title>Flowchart of selection of studies for inclusion in meta-analysis.</title>
<p>A total of 64 studies were identified, and 21 studies were excluded because of duplication. After reading the titles and abstracts, 20 studies were excluded. 23 possible full text studies were carefully reviewed (animal studies [n = 5]; review and meta-analysis [n = 2]; no control group [n = 2]). Finally, 17 trials were included for quantitative analysis.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0180271.g001" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec014">
<title>Qualitative assessment</title>
<p>Study quality was assessed using the Newcastle–Ottawa quality assessment scale; scores ranged from 7 to 8 (with a mean of 7.35), and higher values indicated better methodology. The quality assessment results are shown in <xref ref-type="supplementary-material" rid="pone.0180271.s001">S1 Table</xref> and detailed information for this analysis is provided in <xref ref-type="table" rid="pone.0180271.t001">Table 1</xref>.</p>
<table-wrap id="pone.0180271.t001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0180271.t001</object-id>
<label>Table 1</label> <caption><title>Characteristics of eligible studies.</title></caption>
<alternatives>
<graphic id="pone.0180271.t001g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0180271.t001" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="justify">First Author</th>
<th align="justify">Year</th>
<th align="justify">Origin</th>
<th align="justify">Median age</th>
<th align="justify">sample size</th>
<th align="justify">CD147 distribution</th>
<th align="justify">Type of cancer</th>
<th align="justify">Counting method</th>
<th align="justify">Definition of CD147 positive</th>
<th align="justify">NOS score</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left">Yoshio Ishibashi</td>
<td align="justify">2004</td>
<td align="justify">Japan</td>
<td align="justify">61</td>
<td align="justify">101</td>
<td align="justify">-</td>
<td align="justify">ESCC</td>
<td align="justify">-</td>
<td align="justify">No staining, partial staining, and diffuse and strong staining</td>
<td align="justify">8</td>
</tr>
<tr>
<td align="justify">Zhao JH</td>
<td align="justify">2004</td>
<td align="justify">China</td>
<td align="justify">54.6</td>
<td align="justify">70</td>
<td align="justify">M and C</td>
<td align="justify">ESCC</td>
<td align="justify">A and B</td>
<td align="justify">&gt;0% or weak intensity</td>
<td align="justify">7</td>
</tr>
<tr>
<td align="justify">Cheng, M. F</td>
<td align="justify">2006</td>
<td align="justify">Taiwan</td>
<td align="justify">62.5</td>
<td align="justify">41</td>
<td align="justify">M and C</td>
<td align="justify">ESCC</td>
<td align="justify">A and B</td>
<td align="justify">&gt;0% or weak intensity</td>
<td align="justify">7</td>
</tr>
<tr>
<td align="justify">Zhang HZ</td>
<td align="justify">2006</td>
<td align="justify">China</td>
<td align="justify">58</td>
<td align="justify">85</td>
<td align="justify">M</td>
<td align="justify">ESCC</td>
<td align="justify">B</td>
<td align="justify">Brown</td>
<td align="justify">7</td>
</tr>
<tr>
<td align="justify">Xiong SongBai</td>
<td align="justify">2007</td>
<td align="justify">China</td>
<td align="justify">55.6</td>
<td align="justify">57</td>
<td align="justify">M and C</td>
<td align="justify">ESCC</td>
<td align="justify">A and B</td>
<td align="justify">&gt;0% or weak intensity</td>
<td align="justify">7</td>
</tr>
<tr>
<td align="justify">Xie L</td>
<td align="justify">2008</td>
<td align="justify">China</td>
<td align="justify">53.2</td>
<td align="justify">87</td>
<td align="justify">M and C</td>
<td align="justify">ESCC</td>
<td align="justify">A and B</td>
<td align="justify">&gt;5% or weak intensity</td>
<td align="justify">7</td>
</tr>
<tr>
<td align="justify">Qi Bo</td>
<td align="justify">2008</td>
<td align="justify">China</td>
<td align="justify">58.2</td>
<td align="justify">52</td>
<td align="justify">C</td>
<td align="justify">ESCC</td>
<td align="justify">A and B</td>
<td align="justify">&gt;0% or weak intensity</td>
<td align="justify">8</td>
</tr>
<tr>
<td align="justify">Ma Guang</td>
<td align="justify">2009</td>
<td align="justify">China</td>
<td align="justify">59.5</td>
<td align="justify">70</td>
<td align="justify">M and C</td>
<td align="justify">ESCC</td>
<td align="justify">A and B</td>
<td align="justify">A+B&gt;3</td>
<td align="justify">8</td>
</tr>
<tr>
<td align="justify">Chen JX</td>
<td align="justify">2009</td>
<td align="justify">China</td>
<td align="justify">42</td>
<td align="justify">50</td>
<td align="justify">M and C</td>
<td align="justify">ESCC</td>
<td align="justify">A and B</td>
<td align="justify">&gt;10% or weak intensity</td>
<td align="justify">7</td>
</tr>
<tr>
<td align="justify">Liu HaiMing</td>
<td align="justify">2010</td>
<td align="justify">China</td>
<td align="justify">-</td>
<td align="justify">19</td>
<td align="justify">M and C</td>
<td align="justify">ESCC</td>
<td align="justify">A</td>
<td align="justify">&gt;10%</td>
<td align="justify">7</td>
</tr>
<tr>
<td align="justify">Xiao XiangZhi</td>
<td align="justify">2011</td>
<td align="justify">China</td>
<td align="justify">50</td>
<td align="justify">60</td>
<td align="justify">M and C</td>
<td align="justify">ESCC</td>
<td align="justify">A and B</td>
<td align="justify">A2*B&gt;1</td>
<td align="justify">7</td>
</tr>
<tr>
<td align="justify">Zhu ShaoJun</td>
<td align="justify">2011</td>
<td align="justify">China</td>
<td align="justify">-</td>
<td align="justify">108</td>
<td align="justify">M and C</td>
<td align="justify">ESCC</td>
<td align="justify">A</td>
<td align="justify">&gt;5%</td>
<td align="justify">7</td>
</tr>
<tr>
<td align="justify">Xiong LN</td>
<td align="justify">2011</td>
<td align="justify">China</td>
<td align="justify">-</td>
<td align="justify">40</td>
<td align="justify">M and C</td>
<td align="justify">ESCC</td>
<td align="justify">A</td>
<td align="justify">&gt;5%</td>
<td align="justify">8</td>
</tr>
<tr>
<td align="justify">Zhu, S</td>
<td align="justify">2011</td>
<td align="justify">China</td>
<td align="justify">-</td>
<td align="justify">86</td>
<td align="justify">M and C</td>
<td align="justify">ESCC</td>
<td align="justify">A</td>
<td align="justify">&gt;5%</td>
<td align="justify">7</td>
</tr>
<tr>
<td align="justify">Wan, Y</td>
<td align="justify">2012</td>
<td align="justify">China</td>
<td align="justify">58.8</td>
<td align="justify">80</td>
<td align="justify">M</td>
<td align="justify">ESCC</td>
<td align="justify">A and B</td>
<td align="justify">A3*B≥5</td>
<td align="justify">8</td>
</tr>
<tr>
<td align="justify">Li ChangXiu</td>
<td align="justify">2013</td>
<td align="justify">China</td>
<td align="justify">63.4</td>
<td align="justify">60</td>
<td align="justify">M and C</td>
<td align="justify">ESCC</td>
<td align="justify">A and B</td>
<td align="justify">A4*B≥5</td>
<td align="justify">7</td>
</tr>
<tr>
<td align="justify">Huang, L</td>
<td align="justify">2015</td>
<td align="justify">China</td>
<td align="justify">62.2</td>
<td align="justify">74</td>
<td align="justify">M and C</td>
<td align="justify">Type II/III AEGs</td>
<td align="justify">A and B</td>
<td align="justify">A3*B≥3</td>
<td align="justify">8</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t001fn001"><p>Positive cell percentage (A). A1:0 point for positive cell percentage≤ 25%;1 point for 26%-50%; 2 points for 51%-75%;3 points for&gt;75%. A2: point for positive cell percentage&lt;5%;1 point for 5%-25%,26%-50%;3 points for &gt;50%. A3:0 point for positive cell percentage≤ 5%, 1 point for 6%-25%, 2 points for 26%-50%, 3 points for 51%-75%, and 4 points for &gt;75%. A4: point for positive cell percentage&lt; 1%;1 point for1%-10%; 2 points for11%~50%;3 points for≥51%. Staining intensity (B):0 point for basically no coloration, 1 point for light yellow, 2 points for pale brown, and 3 points for dark brown. M:Membrane,C:Cytoplasm. ESCC:esophageal squamous cell carcinoma. Type II/III AEGs:type II/III adenocarcinoma of esophagogastric junction.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec015">
<title>CD147 and survival analysis</title>
<sec id="sec016">
<title>CD147 expression and overall survival</title>
<p>We analyzed the relationship between CD147 expression and overall survival in EC patients based on the results of two studies[<xref ref-type="bibr" rid="pone.0180271.ref009">9</xref>, <xref ref-type="bibr" rid="pone.0180271.ref015">15</xref>]. Wan and Wu[<xref ref-type="bibr" rid="pone.0180271.ref015">15</xref>] used Kaplan–Meier survival curves and Zhu et al.[<xref ref-type="bibr" rid="pone.0180271.ref009">9</xref>] used Cox regression analyses. In both studies, high CD147 expression was related to poor OS. As shown in <xref ref-type="fig" rid="pone.0180271.g002">Fig 2A</xref>, the data did notexhibit heterogeneity (p = 0.23, <italic>I</italic><sup>2</sup> = 30.1%), and the fixed effects model showed thatthe combined HR was 1.60 (95% CI = (1.19, 2.15), p = 0.02).</p>
<fig id="pone.0180271.g002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0180271.g002</object-id>
<label>Fig 2</label>
<caption>
<title>Survival analysis forest plot.</title>
<p>The squares and horizontal lines correspond to the study- specific OR and 95%CI.The area of the squares reflects the study-specific weight (inverse of the variance). The diamonds represent the pooled OR and 95% CI. The solid vertical line is at the null value (OR = 1). <bold>A</bold> The relationship between CD147 expression and overall survival. CD147 expression was associated with overall survival (HR = 1.60, 95% CI = (1.19, 2.15), p = 0.02). <bold>B</bold> The relationship between CD147 expression and 3-year survival rate. CD147 expression was associated with 3-year survival rate (OR = 3.26, 95%CI = (1.53,6.93),p = 0.02). <bold>C</bold> The relationship between CD147 expression and 5-year survival rate.CD147 expression was associated with 5-year survival rate (OR = 4.35, 95%CI = (2.13, 8.90), p &lt; 0.0001).</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0180271.g002" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec017">
<title>Impact of CD147 on 3-year <ext-link ext-link-type="uri" xlink:href="http://cn.bing.com/dict/clientsearch?mkt=zh-CN&amp;setLang=zh&amp;form=BDVEHC&amp;ClientVer=BDDTV3.5.0.4311&amp;q=3%E5%B9%B4%E7%94%9F%E5%AD%98%E7%8E%87" xlink:type="simple">survival rate</ext-link> of EC</title>
<p>Two reports[<xref ref-type="bibr" rid="pone.0180271.ref007">7</xref>, <xref ref-type="bibr" rid="pone.0180271.ref015">15</xref>] including a total of 154 patients reported an association between CD147 expression and the <ext-link ext-link-type="uri" xlink:href="http://cn.bing.com/dict/clientsearch?mkt=zh-CN&amp;setLang=zh&amp;form=BDVEHC&amp;ClientVer=BDDTV3.5.0.4311&amp;q=3%E5%B9%B4%E7%94%9F%E5%AD%98%E7%8E%87" xlink:type="simple">3</ext-link>-<ext-link ext-link-type="uri" xlink:href="http://cn.bing.com/dict/clientsearch?mkt=zh-CN&amp;setLang=zh&amp;form=BDVEHC&amp;ClientVer=BDDTV3.5.0.4311&amp;q=3%E5%B9%B4%E7%94%9F%E5%AD%98%E7%8E%87" xlink:type="simple">year survival rate.</ext-link> Huang et al.[<xref ref-type="bibr" rid="pone.0180271.ref007">7</xref>] detected CD147 expression in Type II/III AEGs, and Wan and Wu[<xref ref-type="bibr" rid="pone.0180271.ref015">15</xref>] observed CD147 expression in ESCC. Without heterogeneity (p = 0.61, <italic>I</italic><sup>2</sup> = 0%), a fixed-effects model showed that high CD147 expression (57.95%) was statistically significantly associated with a lower <ext-link ext-link-type="uri" xlink:href="http://cn.bing.com/dict/clientsearch?mkt=zh-CN&amp;setLang=zh&amp;form=BDVEHC&amp;ClientVer=BDDTV3.5.0.4311&amp;q=3%E5%B9%B4%E7%94%9F%E5%AD%98%E7%8E%87" xlink:type="simple">3</ext-link>-<ext-link ext-link-type="uri" xlink:href="http://cn.bing.com/dict/clientsearch?mkt=zh-CN&amp;setLang=zh&amp;form=BDVEHC&amp;ClientVer=BDDTV3.5.0.4311&amp;q=3%E5%B9%B4%E7%94%9F%E5%AD%98%E7%8E%87" xlink:type="simple">year survival rate</ext-link> than that of low expression (81.82%) (OR = 3.26, 95% CI = (1.53, 6.93), p = 0.02) (<xref ref-type="fig" rid="pone.0180271.g002">Fig 2B</xref>).</p>
</sec>
<sec id="sec018">
<title>Impact of CD147 on the 5-<ext-link ext-link-type="uri" xlink:href="http://cn.bing.com/dict/clientsearch?mkt=zh-CN&amp;setLang=zh&amp;form=BDVEHC&amp;ClientVer=BDDTV3.5.0.4311&amp;q=3%E5%B9%B4%E7%94%9F%E5%AD%98%E7%8E%87" xlink:type="simple">year survival</ext-link> rate of EC</title>
<p>The association between CD147 and the 5-year survival rate of EC was reported in two studies[<xref ref-type="bibr" rid="pone.0180271.ref007">7</xref>, <xref ref-type="bibr" rid="pone.0180271.ref015">15</xref>]. Both Huang et al.[<xref ref-type="bibr" rid="pone.0180271.ref007">7</xref>] (OR = 4.0, 95% CI = (1.46, 10.95)) and Wan and Wu[<xref ref-type="bibr" rid="pone.0180271.ref015">15</xref>] (OR = 4.75, 95% CI = (1.72, 13.13)) showed that high CD147 expression is statistically significantly associated with a lower 5-year survival rate. Without heterogeneity (p = 0.81, <italic>I</italic><sup>2</sup> = 0%), a significant difference in the 5<ext-link ext-link-type="uri" xlink:href="http://cn.bing.com/dict/clientsearch?mkt=zh-CN&amp;setLang=zh&amp;form=BDVEHC&amp;ClientVer=BDDTV3.5.0.4311&amp;q=3%E5%B9%B4%E7%94%9F%E5%AD%98%E7%8E%87" xlink:type="simple">-year</ext-link> <ext-link ext-link-type="uri" xlink:href="http://cn.bing.com/dict/clientsearch?mkt=zh-CN&amp;setLang=zh&amp;form=BDVEHC&amp;ClientVer=BDDTV3.5.0.4311&amp;q=3%E5%B9%B4%E7%94%9F%E5%AD%98%E7%8E%87" xlink:type="simple">survival rate</ext-link> was detected between groups with high CD147 expression (29.55%) and low CD147 expression (62.12%) assuming a fixed-effects model (OR = 4.35, 95% CI = (2.13, 8.90), p &lt; 0.0001) (<xref ref-type="fig" rid="pone.0180271.g002">Fig 2C</xref>).</p>
</sec>
<sec id="sec019">
<title>CD147 expression and disease-free survival (DFS)</title>
<p>Ishibashi et al.[<xref ref-type="bibr" rid="pone.0180271.ref017">17</xref>] reported an association between CD147 and DFS. The <ext-link ext-link-type="uri" xlink:href="http://cn.bing.com/dict/clientsentence?mkt=zh-CN&amp;setLang=zh&amp;form=BDVEHC&amp;ClientVer=BDDTV3.5.0.4311&amp;q=5%E5%80%8D%E9%A3%8E%E9%99%A9" xlink:type="simple">risk</ext-link> was 1.5 times higher for the high CD147 expression group than the low CD147 expression group (HR = 4.6, 95% CI = 1.55, 13.4), p = 0.006). The pooled HR for DFS showed that high expression of CD147 reduced DFS in EC.</p>
</sec>
</sec>
<sec id="sec020">
<title>CD147 expression in different EC tissues</title>
<sec id="sec021">
<title>CD147 in esophageal cancer and noncancerous tissues</title>
<p>CD147 expression in esophageal cancer and noncancerous tissues was investigated in 14 studies[<xref ref-type="bibr" rid="pone.0180271.ref007">7</xref>, <xref ref-type="bibr" rid="pone.0180271.ref015">15</xref>, <xref ref-type="bibr" rid="pone.0180271.ref017">17</xref>–<xref ref-type="bibr" rid="pone.0180271.ref020">20</xref>, <xref ref-type="bibr" rid="pone.0180271.ref023">23</xref>–<xref ref-type="bibr" rid="pone.0180271.ref030">30</xref>] including 1544 patients. With significant heterogeneity (p &lt; 0.00001, <italic>I</italic><sup>2</sup> = 77%), a random-effects model showed that CD147 expression in esophageal cancer (72.83%) was higher than that in noncancerous tissues (29.19%) (OR = 9.45, 95% CI = (5.39, 16.59), p &lt; 0.00001) (<xref ref-type="fig" rid="pone.0180271.g003">Fig 3A</xref>).</p>
<fig id="pone.0180271.g003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0180271.g003</object-id>
<label>Fig 3</label>
<caption>
<title>Forest plots of CD147 expression and different tissues.</title>
<p>The squares and horizontal lines correspond to the study-specific OR and 95% CI.The area of the squares reflects the study-specific weight (inverse of the variance). The diamonds represent the pooled OR and 95% CI. The solid vertical line is at the null value (OR = 1). <bold>A</bold> CD147 positive expression between cancer and noncancer tissues.Significant difference was found between cancer and noncancer tissues (OR = 9.45, 95%CI = (5.39, 16.59), p &lt; 0.00001). <bold>B</bold> CD147 positive expression between cancer and normal tissues.Significant difference was found between cancer and normal tissues (OR = 12.73, 95%CI = (3.49, 46.46), p = 0.0001). <bold>C</bold> CD147positive expression between cancer and para-carcinoma tissues.Significant difference was found between cancer and para-carcinoma tissues (OR = 12.80, 95%CI = (6.57, 24.92), p &lt; 0.00001). <bold>D</bold> CD147 positive expression between cancer and hyperplastic tissues.Significant difference was found between cancer and hyperplastic tissues (OR = 3.27, 95% CI = (1.47, 7.29), p = 0.004).</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0180271.g003" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec022">
<title>CD147 in esophageal cancer and normal esophageal tissues</title>
<p>Five trials[<xref ref-type="bibr" rid="pone.0180271.ref018">18</xref>, <xref ref-type="bibr" rid="pone.0180271.ref020">20</xref>, <xref ref-type="bibr" rid="pone.0180271.ref024">24</xref>, <xref ref-type="bibr" rid="pone.0180271.ref029">29</xref>, <xref ref-type="bibr" rid="pone.0180271.ref030">30</xref>] reported the expression of CD147 in esophageal cancer tissues and normal esophageal cancer tissues, including 302 esophageal cancer tissues and 91 normal esophageal cancer tissues. With significant heterogeneity (p = 0.02, <italic>I</italic><sup>2</sup> = 66%), a random-effects model showed that CD147 expression was higher inesophageal cancer tissues (78.48%) than in normal tissues (28.57%) (OR = 12.73, 95%CI = (3.49, 46.46), p = 0.0001) (<xref ref-type="fig" rid="pone.0180271.g003">Fig 3B</xref>).</p>
</sec>
<sec id="sec023">
<title>CD147 in esophageal cancer and para-carcinoma tissues</title>
<p>Eleven trials[<xref ref-type="bibr" rid="pone.0180271.ref007">7</xref>, <xref ref-type="bibr" rid="pone.0180271.ref015">15</xref>, <xref ref-type="bibr" rid="pone.0180271.ref017">17</xref>–<xref ref-type="bibr" rid="pone.0180271.ref019">19</xref>, <xref ref-type="bibr" rid="pone.0180271.ref023">23</xref>, <xref ref-type="bibr" rid="pone.0180271.ref025">25</xref>–<xref ref-type="bibr" rid="pone.0180271.ref028">28</xref>, <xref ref-type="bibr" rid="pone.0180271.ref030">30</xref>] investigated the expression of CD147 in esophageal cancer tissues and para-carcinoma tissues, including 700 esophageal cancer tissues and 539 para-carcinoma tissues. A random-effects model showed that CD147 expression was higher in esophageal cancer tissues (71.29%) than in para-carcinoma tissues (17.63%) (OR = 12.80, 95% CI = (6.57, 24.92), p &lt; 0.00001) with significant heterogeneity (p &lt; 0.0001, <italic>I</italic><sup>2</sup> = 75%) (<xref ref-type="fig" rid="pone.0180271.g003">Fig 3C</xref>).</p>
</sec>
<sec id="sec024">
<title>CD147 in esophageal cancer and hyperplastic tissues</title>
<p>Three trials[<xref ref-type="bibr" rid="pone.0180271.ref017">17</xref>, <xref ref-type="bibr" rid="pone.0180271.ref018">18</xref>, <xref ref-type="bibr" rid="pone.0180271.ref029">29</xref>] reported the expression of CD147 in esophageal cancer tissues and hyperplastic tissues, including 273 esophageal cancer tissues and adjacent hyperplastic tissues. A random-effects model showed a difference in the rate of high CD147 expression between the two groups (OR = 3.27, 95% CI = (1.47, 7.29), p = 0.004) with heterogeneity (<italic>I</italic><sup>2</sup> = 59%, p = 0.09) (<xref ref-type="fig" rid="pone.0180271.g003">Fig 3D</xref>).</p>
</sec>
</sec>
<sec id="sec025">
<title>Correlation of CD147 with clinicopathological parameters</title>
<sec id="sec026">
<title>Correlation between CD147 and TNM stage of esophageal cancer tissues</title>
<p>TNM stage is an international standard for tumor staging. TNM stage I–II has a better prognosis than TNM stage III–IV in EC. The association between CD147 and TNM stage was investigated in five studies[<xref ref-type="bibr" rid="pone.0180271.ref007">7</xref>, <xref ref-type="bibr" rid="pone.0180271.ref015">15</xref>, <xref ref-type="bibr" rid="pone.0180271.ref018">18</xref>, <xref ref-type="bibr" rid="pone.0180271.ref023">23</xref>, <xref ref-type="bibr" rid="pone.0180271.ref029">29</xref>]. A fixed-effects model wasused without heterogeneity (p = 0.13, <italic>I</italic><sup>2</sup> = 44%); it indicated a significant difference between the TNM stage III–IV group (83.87%) and TNM stage I–II group (59.17%) (OR = 3.66, 95% CI = (2.20, 6.09), p &lt; 0.00001) (<xref ref-type="fig" rid="pone.0180271.g004">Fig 4A</xref>).</p>
<fig id="pone.0180271.g004" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0180271.g004</object-id>
<label>Fig 4</label>
<caption>
<title>Forest plots of CD147 expression and the clinicopathological features of patients with esophagus cancer.</title>
<p>The squares and horizontal lines correspond to the study- specific OR and 95% CI.The area of the squares reflects the study-specific weight (inverse of the variance). The diamonds represent the pooled OR and 95% CI. The solid vertical line is at the null value (OR = 1). <bold>A</bold> The relationship between CD147 expression and TNM staging. CD147 expression was associated with TNM staging of esophagus cancer(OR = 3.66, 95%CI = (2.20, 6.09), p &lt; 0.00001). <bold>B</bold> The relationship between CD147 expression and tumor depth. CD147 expression was associated with tumor depth (OR = 7.97, 95%CI = (4.13, 15.38), p &lt; 0.00001). <bold>C</bold> The relationship between CD147 expression and status of lymph node.CD147 expression was associated with status of lymph node (OR = 5.14, 95%CI = (2.03, 13.01), p = 0.0005). <bold>D</bold> The relationship between CD147 expression and tumor differentiation.CD147 expression wasn’t associated with tumor differentiation (OR = 1.57, 95%CI = (0.79, 3.12), p = 0.19). <bold>E</bold> The relationship between CD147 expression and age.CD147 expression wasn’t associated with age (OR = 1.05, 95%CI = (0.72,1.53), p = 0.79). <bold>F</bold> The relationship between CD147 expression and sex.CD147 expression wasn’t associated with sex (OR = 0.70, 95%CI = (0.47, 1.04), p = 0.07).</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0180271.g004" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec027">
<title>CD147 with invasive depth of esophageal cancer tissues</title>
<p>Nine studies[<xref ref-type="bibr" rid="pone.0180271.ref015">15</xref>, <xref ref-type="bibr" rid="pone.0180271.ref016">16</xref>, <xref ref-type="bibr" rid="pone.0180271.ref018">18</xref>–<xref ref-type="bibr" rid="pone.0180271.ref020">20</xref>, <xref ref-type="bibr" rid="pone.0180271.ref026">26</xref>–<xref ref-type="bibr" rid="pone.0180271.ref028">28</xref>, <xref ref-type="bibr" rid="pone.0180271.ref031">31</xref>] including 622 tissue samples investigated the relationship between CD147 expression and depth of tumor invasion. With significant heterogeneity (p = 0.07, <italic>I</italic><sup>2</sup> = 45%), a random-effects model showed a significant difference between the pt3/pt4 group (79.44%) and pt1/pt2 group (34.71%) (OR = 7.97, 95% CI = (4.13, 15.38), p &lt; 0.00001) (<xref ref-type="fig" rid="pone.0180271.g004">Fig 4B</xref>).</p>
</sec>
<sec id="sec028">
<title>CD147 with lymph node metastasis of esophageal cancer tissues</title>
<p>Prognosis is often not good when esophageal cancer patients develop lymph node metastasis; accordingly, it is very important to identify indicators of metastasis at an early stage. Thirteen studies[<xref ref-type="bibr" rid="pone.0180271.ref007">7</xref>, <xref ref-type="bibr" rid="pone.0180271.ref015">15</xref>, <xref ref-type="bibr" rid="pone.0180271.ref016">16</xref>, <xref ref-type="bibr" rid="pone.0180271.ref018">18</xref>–<xref ref-type="bibr" rid="pone.0180271.ref020">20</xref>, <xref ref-type="bibr" rid="pone.0180271.ref023">23</xref>, <xref ref-type="bibr" rid="pone.0180271.ref025">25</xref>–<xref ref-type="bibr" rid="pone.0180271.ref029">29</xref>, <xref ref-type="bibr" rid="pone.0180271.ref031">31</xref>] that examined metastasis were included. With significant heterogeneity (p &lt; 0.00001, <italic>I</italic><sup>2</sup> = 83%), a random-effects model showed a significant difference between the lymph node metastasis group (82.58%) and the non-metastasis group (58.86%) (OR = 5.14, 95% CI = (2.03, 13.01), p = 0.0005) (<xref ref-type="fig" rid="pone.0180271.g004">Fig 4C</xref>).</p>
</sec>
<sec id="sec029">
<title>CD147 with differentiation of esophageal cancer tissues</title>
<p>The association between CD147 and histological differentiation was investigated in ten studies[<xref ref-type="bibr" rid="pone.0180271.ref007">7</xref>, <xref ref-type="bibr" rid="pone.0180271.ref015">15</xref>, <xref ref-type="bibr" rid="pone.0180271.ref016">16</xref>, <xref ref-type="bibr" rid="pone.0180271.ref018">18</xref>, <xref ref-type="bibr" rid="pone.0180271.ref020">20</xref>, <xref ref-type="bibr" rid="pone.0180271.ref023">23</xref>, <xref ref-type="bibr" rid="pone.0180271.ref026">26</xref>, <xref ref-type="bibr" rid="pone.0180271.ref028">28</xref>, <xref ref-type="bibr" rid="pone.0180271.ref030">30</xref>, <xref ref-type="bibr" rid="pone.0180271.ref031">31</xref>]. With significant heterogeneity(p = 0.0009, <italic>I</italic><sup>2</sup> = 68%), a random-effects model showed no difference between 234 poorly differentiated tissues (76.50%) and 471 moderately to well differentiated tissues (67.52%) (OR = 1.57, 95% CI = (0.79, 3.12), p = 0.19) (<xref ref-type="fig" rid="pone.0180271.g004">Fig 4D</xref>).</p>
</sec>
<sec id="sec030">
<title>CD147 with age and sex of esophageal cancer tissues</title>
<p>Seven[<xref ref-type="bibr" rid="pone.0180271.ref007">7</xref>, <xref ref-type="bibr" rid="pone.0180271.ref009">9</xref>, <xref ref-type="bibr" rid="pone.0180271.ref015">15</xref>, <xref ref-type="bibr" rid="pone.0180271.ref016">16</xref>, <xref ref-type="bibr" rid="pone.0180271.ref023">23</xref>, <xref ref-type="bibr" rid="pone.0180271.ref026">26</xref>, <xref ref-type="bibr" rid="pone.0180271.ref028">28</xref>] and eight studies[<xref ref-type="bibr" rid="pone.0180271.ref007">7</xref>, <xref ref-type="bibr" rid="pone.0180271.ref009">9</xref>, <xref ref-type="bibr" rid="pone.0180271.ref015">15</xref>, <xref ref-type="bibr" rid="pone.0180271.ref016">16</xref>, <xref ref-type="bibr" rid="pone.0180271.ref018">18</xref>, <xref ref-type="bibr" rid="pone.0180271.ref023">23</xref>, <xref ref-type="bibr" rid="pone.0180271.ref026">26</xref>, <xref ref-type="bibr" rid="pone.0180271.ref028">28</xref>] reported the relationship of CD147 expression with age and sex, respectively. Heterogeneity was not observed in the analysis of CD147 expression with respect to age (p = 0.61, <italic>I</italic><sup>2</sup> = 0%) and sex (p = 0.62, <italic>I</italic><sup>2</sup> = 0%); therefore, a fixed-effect model was used. The results showed that CD147 was not associated with age (OR = 1.05, 95%CI = (0.72, 1.53), p = 0.79) (<xref ref-type="fig" rid="pone.0180271.g004">Fig 4E</xref>) or sex (OR = 0.70, 95% CI = (0.47, 1.04), p = 0.07) (<xref ref-type="fig" rid="pone.0180271.g004">Fig 4F</xref>).</p>
</sec>
</sec>
<sec id="sec031">
<title>Sensitivity analysis and publication bias</title>
<p>A sensitivity analysis was performed to evaluate the stability of the results. As the survival analysis included fewer than three data sets, a different model was used or the sensitivity analysis, i.e., a random effect model. The results indicated stability, as shown in <xref ref-type="table" rid="pone.0180271.t002">Table 2</xref>.</p>
<table-wrap id="pone.0180271.t002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0180271.t002</object-id>
<label>Table 2</label> <caption><title>Summary of the sensitivity analysis of parameters with less than 3 data sets.</title></caption>
<alternatives>
<graphic id="pone.0180271.t002g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0180271.t002" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="justify"/>
<th align="justify">Sample<break/>number</th>
<th align="justify">Fixed model<break/></th>
<th align="justify">Random model</th>
<th align="justify">Heterogeneity<break/></th>
<th align="justify">Publication bias(p value)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="justify">3-year survival rate</td>
<td align="justify">154</td>
<td align="justify">OR = 3.26, 95% CI = (1.53, 6.93)</td>
<td align="justify">OR = 3.25,95% CI = (1.52, 6.92)</td>
<td align="justify"><italic>I</italic><sup>2</sup> = 0.0%, p = 0.606</td>
<td align="justify">1.000</td>
</tr>
<tr>
<td align="justify">5-year survival rate</td>
<td align="justify">154</td>
<td align="justify">OR = 4.35, 95% CI = (2.13, 8.90)</td>
<td align="justify">OR = 4.35, 95% CI = (2.13, 8.90)</td>
<td align="justify"><italic>I</italic><sup>2</sup> = 0.0%, p = 0.814</td>
<td align="justify">1.000</td>
</tr>
<tr>
<td align="justify">Overall survival</td>
<td align="justify">166</td>
<td align="justify">HR = 1.60, 95% CI = (1.19, 2.15)</td>
<td align="justify">HR = 1.71, 95% CI = (1.06, 2.77)</td>
<td align="justify"><italic>I</italic><sup>2</sup> = 30.1%, p = 0.233</td>
<td align="justify">1.000</td>
</tr>
</tbody>
</table>
</alternatives>
</table-wrap>
<p>We excluded studies one-by-one for the sensitivity test for parameters with more than 3 data sets. The sensitivity analysis (<xref ref-type="supplementary-material" rid="pone.0180271.s006">S1 Fig</xref> and <xref ref-type="supplementary-material" rid="pone.0180271.s003">S2 File</xref>) showed that all parameters are stable, except for EC vs. hyperplastic tissues and poorly vs. middle to well differentiated states (<xref ref-type="table" rid="pone.0180271.t003">Table 3</xref>). For publication bias, we used Begg’s test (<xref ref-type="supplementary-material" rid="pone.0180271.s007">S2 Fig</xref> and <xref ref-type="supplementary-material" rid="pone.0180271.s004">S3 File</xref>). Only two parameters (EC vs. noncancerous and lymph node metastasis group) showed publication bias (<xref ref-type="table" rid="pone.0180271.t003">Table 3</xref>). We then used a trim-and-fill method, as described in the Materials and Methods, after omitting studies with small sample sizes. The pooled analysis results were the same as the original results based on all studies.</p>
<table-wrap id="pone.0180271.t003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0180271.t003</object-id>
<label>Table 3</label> <caption><title>Summary of sensitivity analysis of parameters with more than 2 data sets.</title></caption>
<alternatives>
<graphic id="pone.0180271.t003g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0180271.t003" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left"/>
<th align="left">OR Fluctuation</th>
<th align="left">95%CI Fluctuation</th>
<th align="left">Publication bias (p value)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="4"><bold>CD 147 Expression among different tissue</bold></td>
</tr>
<tr>
<td align="justify">EC VS noncancer</td>
<td align="justify">8.55~10.73</td>
<td align="justify">4.87~19.43</td>
<td align="justify">0.024</td>
</tr>
<tr>
<td align="justify">EC vs normal tissue</td>
<td align="justify">9.27~18.43</td>
<td align="justify">2.37~90.29</td>
<td align="justify">1.000</td>
</tr>
<tr>
<td align="justify">EC vs para-EC</td>
<td align="justify">10.82~15.24</td>
<td align="justify">5.83~30.30</td>
<td align="justify">0.074</td>
</tr>
<tr>
<td align="justify">EC vs hyperplastic tissue</td>
<td align="justify">2.48~5.14</td>
<td align="justify">0.93~10.95</td>
<td align="justify">0.296</td>
</tr>
<tr>
<td align="justify" colspan="4"><bold>CD 147 Expression with clinicopathologic characteristics</bold></td>
</tr>
<tr>
<td align="justify">TNM I/II vs TNM III/IV</td>
<td align="justify">2.80~5.31</td>
<td align="justify">1.94~9.59</td>
<td align="justify">1.000</td>
</tr>
<tr>
<td align="justify">pt3/pt4 VS pt1/pt2</td>
<td align="justify">6.64~9.46</td>
<td align="justify">3.54~19.26</td>
<td align="justify">0.536</td>
</tr>
<tr>
<td align="justify">LNM vs LNUM</td>
<td align="justify">4.22~6.50</td>
<td align="justify">1.74~16.32</td>
<td align="justify">0.016</td>
</tr>
<tr>
<td align="justify">Poorly vs middle to well differentiated</td>
<td align="justify">1.33~2.01</td>
<td align="justify">0.67~3.55</td>
<td align="justify">0.721</td>
</tr>
<tr>
<td align="justify">Advance VS Young</td>
<td align="justify">0.95~1.08</td>
<td align="justify">0.63~1.82</td>
<td align="justify">1.000</td>
</tr>
<tr>
<td align="justify">Male vs Female</td>
<td align="justify">0.64~0.80</td>
<td align="justify">0.41~1.18</td>
<td align="justify">0.902</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t003fn001"><p>Note: p &lt; 0.05, exist Publication Bias;EC means esophagus cancer; LNM means lymph node metastasis; LUNM means lymph node unmetastasis.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
</sec>
<sec id="sec032" sec-type="conclusions">
<title>Discussion</title>
<p>CD147 is a 55-kDa molecule found on the surface of tumor cells. It can stimulate the expression of MMPs, which facilitate the invasiveness of cancer cells[<xref ref-type="bibr" rid="pone.0180271.ref017">17</xref>, <xref ref-type="bibr" rid="pone.0180271.ref032">32</xref>]. The correlation between CD147 expression and EC has been investigated extensively. However, the clinical relevance of CD147 remains controversial. Sample size, as a strong predictor in epidemiological studies, may play an important role in resolving this controversy. In the current meta-analysis, we pooled data from 17 studies and demonstrated a remarkable association between CD147 expression and EC. We evaluated the association between CD147 in cancer and other tissues. Based on our results, we concluded that high CD147 expression was significantly associated with malignant tissues.</p>
<p>CD147 stimulates adjacent interstitial normal cells to produce MMPs[<xref ref-type="bibr" rid="pone.0180271.ref033">33</xref>]. MMPs are proteases known to degrade the ECM[<xref ref-type="bibr" rid="pone.0180271.ref034">34</xref>]. Thus, carcinoma cells can interact with adjacent normal cells to produce MMPs via CD147 on their surface, and, in turn, invade lymphatic tissue and blood vessels and penetrate the ECM to reach adjacent organs, with the help of MMPs. Tumor invasion and metastasis are a major barrier to cancer treatment and a main cause of death[<xref ref-type="bibr" rid="pone.0180271.ref035">35</xref>]. The basement membrane and ECM form a histological barrier that can prevent the progression of malignant tumors, and its degradation facilitates tumor progression.</p>
<p>Efforts were made to conduct a comprehensive analysis, but some limitations need to be acknowledged. First, despite our efforts, we did not obtain unpublished data; therefore, the data included in the analyses were from only published data. However, most of the parameters showed no publication bias according to Begg’s test, with the exception of two indicators (EC vs. Noncancerous and lymph node metastasis). We obtained a stable result when studies with small sample sizes were removed. Second, only 4 studies[<xref ref-type="bibr" rid="pone.0180271.ref007">7</xref>, <xref ref-type="bibr" rid="pone.0180271.ref009">9</xref>, <xref ref-type="bibr" rid="pone.0180271.ref015">15</xref>, <xref ref-type="bibr" rid="pone.0180271.ref017">17</xref>] including 341 patients reported survival data. Wan and Wu[<xref ref-type="bibr" rid="pone.0180271.ref015">15</xref>] and Zhu et al. [<xref ref-type="bibr" rid="pone.0180271.ref009">9</xref>]focused on overall survival and Ishibashi et al.[<xref ref-type="bibr" rid="pone.0180271.ref017">17</xref>] considered disease-free survival. Wan and Wu[<xref ref-type="bibr" rid="pone.0180271.ref015">15</xref>] and Huang et al.[<xref ref-type="bibr" rid="pone.0180271.ref007">7</xref>] reported impact of CD147 on the 3-year survival rate and 5-year survival rate. Accordingly, the small sample size is a limitation. Fortunately, we obtained stable results among models in a test of the sensitivity. Last,16 studies reported an association between high CD147 expression and ESCC; therefore, our results were particularly representative of ESCC. Further studies of adenocarcinoma of the esophagus are required to verify these results. However, Huang et al.[<xref ref-type="bibr" rid="pone.0180271.ref007">7</xref>] also showed that high CD147 expression in Type II/III AEGs was significantly associated with cancer tissue types (esophageal cancer versus noncancerous tissues (OR = 11.81, 95%CI = (2.55, 54.64)), poor 3-year survival (OR = 4.05, 95% CI = (1.30, 12.58)), poor 5-year survival (OR = 4.00, 95% CI = (1.46, 10.95)), TNM stage (OR = 4.11, 95% CI = (1.52, 11.14)), lymph node metastasis (OR = 4.40, 95% CI = (1.64, 11.78)), and histological differentiation (OR = 3.30, 95% CI = (1.21, 9.00)). Furthermore, the sensitivity analysis showed that the study of Huang et al.[<xref ref-type="bibr" rid="pone.0180271.ref007">7</xref>] had no influence on the results.</p>
<p>To our knowledge, this meta-analysis is the first study to systematically estimate the association between CD147 expression and the risk of EC and its clinicopathological parameters. Early diagnosis and early treatment are fundamental approaches to improve prognosis[<xref ref-type="bibr" rid="pone.0180271.ref036">36</xref>]. Our results indicated that high CD147 was significantly associated with EC tissues, supporting the notion that CD147 could potentially be applied as a clinical marker for the early diagnosis of EC. We demonstrated that high CD147 expression strongly predicted a poorer TNM stage, invasion depth, lymph node metastasis, and a worse survival rate in patients with EC. In conclusion, CD147 was an important molecule for the diagnosis and estimating the prognosis of patients with EC. Further studies using additional putative EC surface markers in combination with CD147 are required to evaluate their potential use in predicting patient outcomes.</p>
</sec>
<sec id="sec033">
<title>Supporting information</title>
<supplementary-material id="pone.0180271.s001" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pone.0180271.s001" xlink:type="simple">
<label>S1 Table</label>
<caption>
<title>NOS score.</title>
<p>(DOCX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0180271.s002" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pone.0180271.s002" xlink:type="simple">
<label>S1 File</label>
<caption>
<title>Searching strategy.</title>
<p>(DOCX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0180271.s003" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pone.0180271.s003" xlink:type="simple">
<label>S2 File</label>
<caption>
<title>Sensitivity analysis plot legend.</title>
<p>(DOCX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0180271.s004" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pone.0180271.s004" xlink:type="simple">
<label>S3 File</label>
<caption>
<title>Begg's plot legend.</title>
<p>(DOCX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0180271.s005" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pone.0180271.s005" xlink:type="simple">
<label>S4 File</label>
<caption>
<title>PRISMA 2009 checklist.</title>
<p>(DOC)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0180271.s006" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pone.0180271.s006" xlink:type="simple">
<label>S1 Fig</label>
<caption>
<title>Sensitivity analysis plot.</title>
<p>(TIF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0180271.s007" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pone.0180271.s007" xlink:type="simple">
<label>S2 Fig</label>
<caption>
<title>Begg's plot.</title>
<p>(TIF)</p>
</caption>
</supplementary-material>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="pone.0180271.ref001"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Siegel</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Ma</surname> <given-names>JM</given-names></name>and<name name-style="western"><surname>Zou</surname> <given-names>ZH</given-names></name>. ct al. <article-title>Cancer Statistics, 2014</article-title>. <source>Ca Cancer J Clin</source>. <year>2014</year>; <volume>64</volume>(<fpage>1</fpage>–<lpage>21</lpage>.</mixed-citation></ref>
<ref id="pone.0180271.ref002"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tang</surname> <given-names>WR</given-names></name>, <name name-style="western"><surname>Fang</surname> <given-names>JY</given-names></name>, <name name-style="western"><surname>Wu</surname> <given-names>KS</given-names></name>, <name name-style="western"><surname>Shi</surname> <given-names>XJ</given-names></name>, <name name-style="western"><surname>Luo</surname> <given-names>JY</given-names></name>and<name name-style="western"><surname>Lin</surname> <given-names>K</given-names></name>. <article-title>Epidemiological characteristics and prediction of esophageal cancer mortality in China from 1991 to 2012</article-title>. <source>Asian Pac J Cancer Prev</source>. <year>2014</year>; <volume>15</volume>(<issue>16</issue>):<fpage>6929</fpage>–<lpage>34</lpage>. <object-id pub-id-type="pmid">25169548</object-id></mixed-citation></ref>
<ref id="pone.0180271.ref003"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jiang</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Zhao</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Meng</surname> <given-names>X</given-names></name>and<name name-style="western"><surname>Yu</surname> <given-names>J</given-names></name>. <article-title>Involved field irradiation for the treatment of esophageal cancer: is it better than elective nodal irradiation?</article-title> <source>CANCER LETT</source>. <year>2015</year>; <volume>357</volume>(<issue>1</issue>):<fpage>69</fpage>–<lpage>74</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.canlet.2014.11.045" xlink:type="simple">10.1016/j.canlet.2014.11.045</ext-link></comment> <object-id pub-id-type="pmid">25464112</object-id></mixed-citation></ref>
<ref id="pone.0180271.ref004"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Abdel-Latif</surname> <given-names>MM</given-names></name>, <name name-style="western"><surname>Kelleher</surname> <given-names>D</given-names></name>and<name name-style="western"><surname>Reynolds</surname> <given-names>JV</given-names></name>. <article-title>Molecular mechanisms of constitutive and inducible NF-kappaB activation in oesophageal adenocarcinoma</article-title>. <source>EUR J CANCER</source>. <year>2015</year>; <volume>51</volume>(<issue>4</issue>):<fpage>464</fpage>–<lpage>72</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ejca.2014.11.014" xlink:type="simple">10.1016/j.ejca.2014.11.014</ext-link></comment> <object-id pub-id-type="pmid">25596807</object-id></mixed-citation></ref>
<ref id="pone.0180271.ref005"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhang</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Ye</surname> <given-names>SB</given-names></name>, <name name-style="western"><surname>Ma</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Tang</surname> <given-names>XF</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>SP</given-names></name>, <name name-style="western"><surname>He</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>WL</given-names></name>, <name name-style="western"><surname>Xie</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Zeng</surname> <given-names>YX</given-names></name>and<name name-style="western"><surname>Li</surname> <given-names>J</given-names></name>. <article-title>The expressions of MIF and CXCR4 protein in tumor microenvironment are adverse prognostic factors in patients with esophageal squamous cell carcinoma</article-title>. <source>J TRANSL MED</source>. <year>2013</year>; <volume>11</volume>(<fpage>60</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/1479-5876-11-60" xlink:type="simple">10.1186/1479-5876-11-60</ext-link></comment> <object-id pub-id-type="pmid">23497377</object-id></mixed-citation></ref>
<ref id="pone.0180271.ref006"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname> <given-names>CY</given-names></name>, <name name-style="western"><surname>Deng</surname> <given-names>JY</given-names></name>, <name name-style="western"><surname>Cai</surname> <given-names>XW</given-names></name>, <name name-style="western"><surname>Fu</surname> <given-names>XL</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Zhou</surname> <given-names>XY</given-names></name>, <name name-style="western"><surname>Wu</surname> <given-names>XH</given-names></name>, <name name-style="western"><surname>Hu</surname> <given-names>XC</given-names></name>, <name name-style="western"><surname>Fan</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Xiang</surname> <given-names>JQ</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>YW</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>HQ</given-names></name>, <name name-style="western"><surname>Perez</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Jiang</surname> <given-names>GL</given-names></name>and<name name-style="western"><surname>Zhao</surname> <given-names>KL</given-names></name>. <article-title>High EGFR and low p-Akt expression is associated with better outcome after nimotuzumab-containing treatment in esophageal cancer patients: preliminary clinical result and testable hypothesis</article-title>. <source>ONCOTARGET</source>. <year>2015</year>; <volume>6</volume>(<issue>21</issue>):<fpage>18674</fpage>–<lpage>82</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.18632/oncotarget.4367" xlink:type="simple">10.18632/oncotarget.4367</ext-link></comment> <object-id pub-id-type="pmid">26124180</object-id></mixed-citation></ref>
<ref id="pone.0180271.ref007"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Huang</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Xu</surname> <given-names>AM</given-names></name>and<name name-style="western"><surname>Peng</surname> <given-names>Q</given-names></name>. <article-title>CD147 and MMP-9 expressions in type II/III adenocarcinoma of esophagogastric junction and their clinicopathological significances</article-title>. <source>Int J Clin Exp Pathol</source>. <year>2015</year>; <volume>8</volume>(<issue>2</issue>):<fpage>1929</fpage>–<lpage>37</lpage>. <object-id pub-id-type="pmid">25973085</object-id></mixed-citation></ref>
<ref id="pone.0180271.ref008"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Peng</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Ning</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Yang</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>F</given-names></name>and<name name-style="western"><surname>Wu</surname> <given-names>Y</given-names></name>. <article-title>CD147 and Prostate Cancer: A Systematic Review and Meta-Analysis</article-title>. <source>PLOS ONE</source>. <year>2016</year>; <volume>11</volume>(<issue>9</issue>):<fpage>e163678</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0163678" xlink:type="simple">10.1371/journal.pone.0163678</ext-link></comment> <object-id pub-id-type="pmid">27684938</object-id></mixed-citation></ref>
<ref id="pone.0180271.ref009"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhu</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Mi</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Gong</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Han</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Yao</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Lan</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>Z</given-names></name>and<name name-style="western"><surname>Zhang</surname> <given-names>W</given-names></name>. <article-title>Clinical impact of HAb18G/CD147 expression in esophageal squamous cell carcinoma</article-title>. <source>Dig Dis Sci</source>. <year>2011</year>; <volume>56</volume>(<issue>12</issue>):<fpage>3569</fpage>–<lpage>76</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s10620-011-1812-x" xlink:type="simple">10.1007/s10620-011-1812-x</ext-link></comment> <object-id pub-id-type="pmid">21789540</object-id></mixed-citation></ref>
<ref id="pone.0180271.ref010"><label>10</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hemdan</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Malmstrom</surname> <given-names>PU</given-names></name>, <name name-style="western"><surname>Jahnson</surname> <given-names>S</given-names></name>and<name name-style="western"><surname>Segersten</surname> <given-names>U</given-names></name>. <article-title>Emmprin Expression Predicts Response and Survival following Cisplatin Containing Chemotherapy for Bladder Cancer: A Validation Study</article-title>. <source>J Urol</source>. <year>2015</year>; <volume>194</volume>(<issue>6</issue>):<fpage>1575</fpage>–<lpage>81</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.juro.2015.06.085" xlink:type="simple">10.1016/j.juro.2015.06.085</ext-link></comment> <object-id pub-id-type="pmid">26119672</object-id></mixed-citation></ref>
<ref id="pone.0180271.ref011"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhao</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Ye</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Wu</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Yang</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Gao</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Yang</surname> <given-names>H</given-names></name>and<name name-style="western"><surname>Li</surname> <given-names>Y</given-names></name>. <article-title>Sp1-CD147 positive feedback loop promotes the invasion ability of ovarian cancer</article-title>. <source>ONCOL REP</source>. <year>2015</year>; <volume>34</volume>(<issue>1</issue>):<fpage>67</fpage>–<lpage>76</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3892/or.2015.3999" xlink:type="simple">10.3892/or.2015.3999</ext-link></comment> <object-id pub-id-type="pmid">25998266</object-id></mixed-citation></ref>
<ref id="pone.0180271.ref012"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname> <given-names>Q</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>JG</given-names></name>and<name name-style="western"><surname>Wang</surname> <given-names>W</given-names></name>. <article-title>Expression and significance of S100P, CD147, and OCT4 in different prostate cancer tissue TNM stages</article-title>. <source>GENET MOL RES</source>. <year>2015</year>; <volume>14</volume>(<issue>2</issue>):<fpage>6844</fpage>–<lpage>51</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.4238/2015.June.18.27" xlink:type="simple">10.4238/2015.June.18.27</ext-link></comment> <object-id pub-id-type="pmid">26125892</object-id></mixed-citation></ref>
<ref id="pone.0180271.ref013"><label>13</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Li</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Wu</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Shi</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Xu</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Wei</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>J</given-names></name>and<name name-style="western"><surname>Liu</surname> <given-names>Y</given-names></name>. <article-title>Expression and clinical significance of CD147 in renal cell carcinoma: a meta-analysis</article-title>. <source>ONCOTARGET</source>. <year>2017</year>; <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.18632/oncotarget.17376" xlink:type="simple">10.18632/oncotarget.17376</ext-link></comment> <object-id pub-id-type="pmid">28488587</object-id></mixed-citation></ref>
<ref id="pone.0180271.ref014"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Li</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Xi</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Dai</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Wu</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>Y</given-names></name>and<name name-style="western"><surname>Zhang</surname> <given-names>H</given-names></name>. <article-title>CD147 and glioma: a meta-analysis</article-title>. <source>J Neurooncol</source>. <year>2017</year>; <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s11060-017-2499-4" xlink:type="simple">10.1007/s11060-017-2499-4</ext-link></comment> <object-id pub-id-type="pmid">28560663</object-id></mixed-citation></ref>
<ref id="pone.0180271.ref015"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wan</surname> <given-names>Y</given-names></name>and<name name-style="western"><surname>Wu</surname> <given-names>XY</given-names></name>. [<article-title>Expression and clinical significance of DAPK1 and CD147 in esophageal squamous cell carcinoma</article-title>]. <source>Zhonghua Zhong Liu Za Zhi</source>. <year>2012</year>; <volume>34</volume>(<issue>1</issue>):<fpage>44</fpage>–<lpage>8</lpage>. <object-id pub-id-type="pmid">22490855</object-id></mixed-citation></ref>
<ref id="pone.0180271.ref016"><label>16</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhu</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Mi</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Gong</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Han</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Yao</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>LAN</surname> <given-names>M</given-names></name>and<name name-style="western"><surname>Zhang</surname> <given-names>W</given-names></name>. <article-title>Significance and expression of HAb18G/CD147 in esophageal squamous cell carcinoma</article-title>. <source>CHINESE JOURNAL OF CELLULAR AND MOLECULAR IMMUNOLOGY</source>. <year>2011</year>; <volume>07</volume>):<fpage>784</fpage>–<lpage>6</lpage>.</mixed-citation></ref>
<ref id="pone.0180271.ref017"><label>17</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ishibashi</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Matsumoto</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Niwa</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Suzuki</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Omura</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Hanyu</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Nakada</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Yanaga</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Yamada</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Ohkawa</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Kawakami</surname> <given-names>M</given-names></name>and<name name-style="western"><surname>Urashima</surname> <given-names>M</given-names></name>. <article-title>CD147 and matrix metalloproteinase-2 protein expression as significant prognostic factors in esophageal squamous cell carcinoma</article-title>. <source>CANCER-AM CANCER SOC</source>. <year>2004</year>; <volume>101</volume>(<issue>9</issue>):<fpage>1994</fpage>–<lpage>2000</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/cncr.20593" xlink:type="simple">10.1002/cncr.20593</ext-link></comment> <object-id pub-id-type="pmid">15372476</object-id></mixed-citation></ref>
<ref id="pone.0180271.ref018"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhang</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Hua</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Yi</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>J</given-names></name>and<name name-style="western"><surname>Wu</surname> <given-names>D</given-names></name>. <article-title>Expression and clinical significance of extracellular matrix metalloproteinase inducer in squamous cellular carcinoma of esophagus</article-title>. <source>CHINESE JOURNAL OF EXPERIMENTAL SURGERY</source>. <year>2006</year>; <volume>10</volume>):<fpage>1248</fpage>–<lpage>50</lpage>.</mixed-citation></ref>
<ref id="pone.0180271.ref019"><label>19</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Li-na</surname> <given-names>X</given-names></name>and<name name-style="western"><surname>Zhi-fan</surname> <given-names>X</given-names></name>. <article-title>Significance and expression of CD147 and nuclear factor-κB and epithelial growth factor receptor in esophageal squamous cell carcinoma</article-title>. <source>CLINICAL FOCUS</source>. <year>2011</year>; <volume>01</volume>):<fpage>20</fpage>–<lpage>2</lpage>.</mixed-citation></ref>
<ref id="pone.0180271.ref020"><label>20</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Guang</surname> <given-names>MA</given-names></name>, <name name-style="western"><surname>Zhian</surname> <given-names>G</given-names></name>and<name name-style="western"><surname>Yuhua</surname> <given-names>Z</given-names></name>. <article-title>Significance of Expressions of CD147, MMP-2 and VEGF in Esophageal Squamous Cell Carcinoma</article-title>. <source>Journal of New Medicine</source>. <year>2009</year>; <volume>19</volume>(<issue>1</issue>):<fpage>12</fpage>–<lpage>5</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3969/j.issn.1004-5511.2009.01.004" xlink:type="simple">10.3969/j.issn.1004-5511.2009.01.004</ext-link></comment></mixed-citation></ref>
<ref id="pone.0180271.ref021"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Wells G A, Shea B, O Connell D, Peterson J E A, Welch VandEA Losos M. the Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses.; 2000.</mixed-citation></ref>
<ref id="pone.0180271.ref022"><label>22</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Duval</surname> <given-names>S</given-names></name>and<name name-style="western"><surname>Tweedie</surname> <given-names>R</given-names></name>. <article-title>Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis</article-title>. <source>BIOMETRICS</source>. <year>2000</year>; <volume>56</volume>(<issue>2</issue>):<fpage>455</fpage>–<lpage>63</lpage>. <object-id pub-id-type="pmid">10877304</object-id></mixed-citation></ref>
<ref id="pone.0180271.ref023"><label>23</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Xiao</surname> <given-names>X</given-names></name>. <article-title>The clinical research on the relationship between the expression of cd147 and mmp-2 with biological beheavior in esophgeal cancer</article-title>. <source>Taishan Medical University</source>. <year>2011</year>; <volume>05</volume>):<fpage>58</fpage>.</mixed-citation></ref>
<ref id="pone.0180271.ref024"><label>24</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Haiming</surname> <given-names>L</given-names></name>and<name name-style="western"><surname>Junfeng</surname> <given-names>D</given-names></name>. <article-title>The Expression of CD147 and MMP-2 in Human Early Esophageal Carcinoma</article-title>. <source>CHINA FOREIGN MEDICAL TREATMENT</source>. <year>2010</year>; <volume>29</volume>):<fpage>3</fpage>–<lpage>5</lpage>.</mixed-citation></ref>
<ref id="pone.0180271.ref025"><label>25</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jin-xu</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Ke-jun</surname> <given-names>C</given-names></name>and<name name-style="western"><surname>Yue-xin</surname> <given-names>C</given-names></name>. <article-title>Relationship between Metastasis of Esophageal Squamous Cell Carcinoma and Expression of CD147, MMP9 and S100A4</article-title>. <source>CANCER RESEARCH ON PREVENTION AND TREATMENT</source>. <year>2009</year>; <volume>07</volume>):<fpage>596</fpage>–<lpage>9</lpage>.</mixed-citation></ref>
<ref id="pone.0180271.ref026"><label>26</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chang-xiu</surname> <given-names>LI</given-names></name>, <name name-style="western"><surname>Hong-mei</surname> <given-names>XU</given-names></name>, <name name-style="western"><surname>Da-rong</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Shi-jun</surname> <given-names>WU</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>Z</given-names></name>and<name name-style="western"><surname>Zhi-bin</surname> <given-names>L</given-names></name>. <article-title>The expressions of CD147,PTEN and E-cadherin in esophageal carcinoma and their correlation with clinical-pathological characteristics</article-title>. <source>LABORATORY MEDICINE AND CLINIC</source>. <year>2013</year>; <volume>10</volume>(<issue>2</issue>):<fpage>129</fpage>–<lpage>31</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3969/j.issn.1672-9455.2013.02.001" xlink:type="simple">10.3969/j.issn.1672-9455.2013.02.001</ext-link></comment></mixed-citation></ref>
<ref id="pone.0180271.ref027"><label>27</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>B</surname> <given-names>Q</given-names></name>, <name name-style="western"><surname>Shi</surname> <given-names>Q</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>S</given-names></name>and<name name-style="western"><surname>Zhao</surname> <given-names>B</given-names></name>. <article-title>Expression of matrix metalloproteinase-9,tissue inhibitor of metalloproteinase-1 and CD147 in esophageal squamous cell cancer</article-title>. <source>MEDICAL INFORMATION SECTION OF OPERATIVE SURGERY</source>. <year>2008</year>; <volume>10</volume>):<fpage>886</fpage>–<lpage>8</lpage>.</mixed-citation></ref>
<ref id="pone.0180271.ref028"><label>28</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Song-bai</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Yi</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Bing</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Xiao-xing</surname> <given-names>Z</given-names></name>and<name name-style="western"><surname>Kang</surname> <given-names>Y</given-names></name>. <article-title>Expression of Matrix Metalloproteinases -9 and CD- 147 in Human Esophageal Squamous Cell Carcinoma</article-title>. <source>PROGRESS IN MODERN BIOMEDICINE.</source> <year>2007</year>; <volume>01</volume>):<fpage>42</fpage>–<lpage>3</lpage>.</mixed-citation></ref>
<ref id="pone.0180271.ref029"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ling</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Zhi-dong</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Dong-ping</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Qi</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Yong-hu</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Zhi-jun</surname> <given-names>C</given-names></name>and<name name-style="western"><surname>Tie-jun</surname> <given-names>R</given-names></name>. <article-title>Expression of fibronectin, laminin and extracellular matrix metalloproteinase inducer in esophageal Carcinoma</article-title>. <source>JOURNAL OF INTERNATIONAL ONCOLOGY</source>. <year>2008</year>; <volume>35</volume>(<issue>2</issue>):<fpage>156</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3760/cma.j.issn.1673-422X.2008.02.025" xlink:type="simple">10.3760/cma.j.issn.1673-422X.2008.02.025</ext-link></comment></mixed-citation></ref>
<ref id="pone.0180271.ref030"><label>30</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cheng</surname> <given-names>MF</given-names></name>, <name name-style="western"><surname>Tzao</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Tsai</surname> <given-names>WC</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>WH</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Chiang</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Sheu</surname> <given-names>LF</given-names></name>and<name name-style="western"><surname>Jin</surname> <given-names>JS</given-names></name>. <article-title>Expression of EMMPRIN and matriptase in esophageal squamous cell carcinoma: correlation with clinicopathological parameters</article-title>. <source>DIS ESOPHAGUS</source>. <year>2006</year>; <volume>19</volume>(<issue>6</issue>):<fpage>482</fpage>–<lpage>6</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/j.1442-2050.2006.00613.x" xlink:type="simple">10.1111/j.1442-2050.2006.00613.x</ext-link></comment> <object-id pub-id-type="pmid">17069593</object-id></mixed-citation></ref>
<ref id="pone.0180271.ref031"><label>31</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhao</surname> <given-names>J</given-names></name>and<name name-style="western"><surname>Fan</surname> <given-names>K</given-names></name>. <article-title>Expression and Significance of Matrix Metalloproteinase-2 and CD147 in Esophageal Squamous Cell Carcinoma</article-title>. <source>ACTA UNIVERSITATIS MEDICINALIS NANJING(NATURAL SCIENCE)</source>. <year>2004</year>; <volume>06</volume>):<fpage>621</fpage>–<lpage>3</lpage>.</mixed-citation></ref>
<ref id="pone.0180271.ref032"><label>32</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Reimers</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Zafrakas</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Assmann</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Egen</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Riethdorf</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Riethdorf</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Berger</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Ebel</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Janicke</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Sauter</surname> <given-names>G</given-names></name>and<name name-style="western"><surname>Pantel</surname> <given-names>K</given-names></name>. <article-title>Expression of extracellular matrix metalloproteases inducer on micrometastatic and primary mammary carcinoma cells</article-title>. <source>CLIN CANCER RES</source>. <year>2004</year>; <volume>10</volume>(<issue>10</issue>):<fpage>3422</fpage>–<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1158/1078-0432.CCR-03-0610" xlink:type="simple">10.1158/1078-0432.CCR-03-0610</ext-link></comment> <object-id pub-id-type="pmid">15161697</object-id></mixed-citation></ref>
<ref id="pone.0180271.ref033"><label>33</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ellis</surname> <given-names>SM</given-names></name>, <name name-style="western"><surname>Nabeshima</surname> <given-names>K</given-names></name>and<name name-style="western"><surname>Biswas</surname> <given-names>C</given-names></name>. <article-title>Monoclonal antibody preparation and purification of a tumor cell collagenase-stimulatory factor</article-title>. <source>CANCER RES</source>. <year>1989</year>; <volume>49</volume>(<issue>12</issue>):<fpage>3385</fpage>–<lpage>91</lpage>. <object-id pub-id-type="pmid">2541902</object-id></mixed-citation></ref>
<ref id="pone.0180271.ref034"><label>34</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Basset</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Bellocq</surname> <given-names>JP</given-names></name>, <name name-style="western"><surname>Wolf</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Stoll</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Hutin</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Limacher</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>Podhajcer</surname> <given-names>OL</given-names></name>, <name name-style="western"><surname>Chenard</surname> <given-names>MP</given-names></name>, <name name-style="western"><surname>Rio</surname> <given-names>MC</given-names></name>and<name name-style="western"><surname>Chambon</surname> <given-names>P</given-names></name>. <article-title>A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas</article-title>. <source>NATURE</source>. <year>1990</year>; <volume>348</volume>(<issue>6303</issue>):<fpage>699</fpage>–<lpage>704</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/348699a0" xlink:type="simple">10.1038/348699a0</ext-link></comment> <object-id pub-id-type="pmid">1701851</object-id></mixed-citation></ref>
<ref id="pone.0180271.ref035"><label>35</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gilkes</surname> <given-names>DM</given-names></name>, <name name-style="western"><surname>Semenza</surname> <given-names>GL</given-names></name>and<name name-style="western"><surname>Wirtz</surname> <given-names>D</given-names></name>. <article-title>Hypoxia and the extracellular matrix: drivers of tumour metastasis</article-title>. <source>NAT REV CANCER</source>. <year>2014</year>; <volume>14</volume>(<issue>6</issue>):<fpage>430</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nrc3726" xlink:type="simple">10.1038/nrc3726</ext-link></comment> <object-id pub-id-type="pmid">24827502</object-id></mixed-citation></ref>
<ref id="pone.0180271.ref036"><label>36</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Huang</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Xu</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Han</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Wu</surname> <given-names>S</given-names></name>and<name name-style="western"><surname>Wang</surname> <given-names>Y</given-names></name>. <article-title>Detection of perioperative cancer antigen 72–4 in gastric juice pre- and post-distal gastrectomy and its significances</article-title>. <source>MED ONCOL</source>. <year>2013</year>; <volume>30</volume>(<issue>3</issue>):<fpage>651</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s12032-013-0651-3" xlink:type="simple">10.1007/s12032-013-0651-3</ext-link></comment> <object-id pub-id-type="pmid">23820956</object-id></mixed-citation></ref>
</ref-list>
</back>
</article>